These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6881138)
1. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. Pentchev PG; Neumeyer B; Svennerholm L; Groth CG; Brady RO Am J Hum Genet; 1983 Jul; 35(4):621-8. PubMed ID: 6881138 [TBL] [Abstract][Full Text] [Related]
2. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease. Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026 [TBL] [Abstract][Full Text] [Related]
3. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue. Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293 [TBL] [Abstract][Full Text] [Related]
4. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts. Choudary PV; Barranger JA; Tsuji S; Mayor J; LaMarca ME; Cepko CL; Mulligan RC; Ginns EI Mol Biol Med; 1986 Jun; 3(3):293-9. PubMed ID: 3736391 [TBL] [Abstract][Full Text] [Related]
5. Cross-reacting material in Gaucher disease fibroblasts. Beutler E; Kuhl W; Sorge J Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6506-10. PubMed ID: 6593712 [TBL] [Abstract][Full Text] [Related]
6. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. Ginns EI; Brady RO; Pirruccello S; Moore C; Sorrell S; Furbish FS; Murray GJ; Tager J; Barranger JA Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5607-10. PubMed ID: 6957882 [TBL] [Abstract][Full Text] [Related]
7. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations. Grace ME; Graves PN; Smith FI; Grabowski GA J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100 [TBL] [Abstract][Full Text] [Related]
8. Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Dahl N; Lagerström M; Erikson A; Pettersson U Am J Hum Genet; 1990 Aug; 47(2):275-8. PubMed ID: 2378352 [TBL] [Abstract][Full Text] [Related]
9. Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease. Aerts JM; Sa Miranda MC; Brouwer-Kelder EM; Van Weely S; Barranger JA; Tager JM Biochim Biophys Acta; 1990 Oct; 1041(1):55-63. PubMed ID: 2223847 [TBL] [Abstract][Full Text] [Related]
10. Glucocerebrosidase "processing" and gene expression in various forms of Gaucher disease. Beutler E; Kuhl W; Sorge J Am J Hum Genet; 1985 Nov; 37(6):1062-70. PubMed ID: 4083278 [TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Tsuji S; Martin BM; Barranger JA; Stubblefield BK; LaMarca ME; Ginns EI Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2349-52. PubMed ID: 3353383 [TBL] [Abstract][Full Text] [Related]
12. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder. Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E J Clin Invest; 1990 Jan; 85(1):219-22. PubMed ID: 2295698 [TBL] [Abstract][Full Text] [Related]
13. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts. Jonsson LM; Murray GJ; Sorrell SH; Strijland A; Aerts JF; Ginns EI; Barranger JA; Tager JM; Schram AW Eur J Biochem; 1987 Apr; 164(1):171-9. PubMed ID: 3549301 [TBL] [Abstract][Full Text] [Related]
14. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells. Choy FY; Wei C; Levin D Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741 [TBL] [Abstract][Full Text] [Related]
15. Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease. Ginns EI; Choudary PV; Tsuji S; Martin B; Stubblefield B; Sawyer J; Hozier J; Barranger JA Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7101-5. PubMed ID: 3863141 [TBL] [Abstract][Full Text] [Related]
16. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts. Van Weely S; Van Leeuwen MB; Jansen ID; De Bruijn MA; Brouwer-Kelder EM; Schram AW; Sa Miranda MC; Barranger JA; Petersen EM; Goldblatt J Biochim Biophys Acta; 1991 Jun; 1096(4):301-11. PubMed ID: 1829642 [TBL] [Abstract][Full Text] [Related]
17. The human glucocerebrosidase gene has two functional ATG initiator codons. Sorge JA; West C; Kuhl W; Treger L; Beutler E Am J Hum Genet; 1987 Dec; 41(6):1016-24. PubMed ID: 3687939 [TBL] [Abstract][Full Text] [Related]
18. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease. Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355 [No Abstract] [Full Text] [Related]
20. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts. Choy FY Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]